Total raised
—
Last: Undisclosed 2022-01
Stage
Seed
Founded
2021
Headcount
5
HQ
Herzliya
Sector
Agriculture & Food Technologies
About
RNAway develops and markets a patented platform technology to deliver RNA molecules into the plant by spray or irrigation for a variety of agricultural applications. The company is based on ground-breaking research leveraging nanotechnology, drug delivery and gene therapy expertise. RNAway offers crop protection companies the opportunity to utilize its POCs and further develop them to commercialized products.
Funding history · 1 round · — total
2022-01
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is RNAway's core technology?
- RNAway develops and markets a patented platform technology for delivering RNA molecules into plants via spray or irrigation for various agricultural applications.
- When was RNAway founded?
- RNAway was founded in February 2021.
- Where is RNAway headquartered?
- RNAway is headquartered in Herzliya, Israel.
- How many employees does RNAway have?
- RNAway has between 1 and 10 employees.
- Has RNAway received any funding?
- RNAway received an undisclosed funding round in January 2022, with Copia Agro & Food as an investor. For full financing history, refer to startupim.
- What is RNAway's current funding stage?
- RNAway is currently in the Seed funding stage.
- What sectors does RNAway operate in?
- RNAway operates in Agriculture & Food Technologies, Ag Tech, and Genetics & Input sectors.
- Does RNAway hold any patents?
- Yes, RNAway holds one patent related to its technology.
Sectors & technology
Primary sector
Agriculture & Food Technologies
Sub-sectors
Agriculture & Food TechnologiesAg TechGenetics & Input
Technologies
BiologicalsMolecules
Target customers
Agriculture & FoodCrops
Business model
B2B
Highlights
1 Patents
Tags
geneticsnanotechnologyagtech